Healthtech Startups

Hacomono builds a platform connecting users, fitness facilities, healthcare providers, and instructors to promote wellness as part of everyday life in Japan. The company provides digital infrastructure for gyms and sports facilities through SaaS, IoT, fintech, and e-commerce solutions.

6 investors

01Health provides an AI-powered platform that enables local healthcare providers to deliver specialist care by embedding clinical protocols, expert oversight, and patient workflows into their practices. The company addresses healthcare access gaps by allowing clinics to offer specialist-level treatment in-house without requiring patients to travel or wait months for appointments.

5 investors

1upHealth provides a FHIR-first health data platform that helps health plans and payers acquire, manage, and exchange healthcare data, including automating prior authorization, member data access, and provider directories. It supports interoperability and compliance with CMS regulations across Medicare, Medicaid, and commercial lines of business in the U.S.

5 investors

2AB BioscienceS develops first-in-class small molecule therapeutics targeting the 5-HT2A receptor for ophthalmology and central nervous system disorders. The platform uses structure-guided design to create therapies aimed at tissue regeneration, inflammation resolution, and neural circuit restoration.

5 investors

52North Health develops NeutroCheck, a diagnostic tool that identifies neutropenia in chemotherapy patients presenting with fever, enabling risk stratification and reducing unnecessary emergency department visits.

5 investors

Abett offers a data management platform that integrates, validates, and manages healthcare and benefits data for large employers and health plans. The platform automates member engagement matching and outcome measurement for healthcare organizations.

5 investors

Abion is a biotech company focused on precision oncology, researching and developing novel anticancer drugs. It works to identify and commercialize new drug candidates and conduct global clinical trials for rare and hard-to-treat diseases, partnering with domestic and international biopharma companies.

5 investors

Abogen is a biotechnology company developing mRNA-based therapeutics and vaccines, including an mRNA shingles vaccine and mRNA-encoded T-cell engagers for cancer such as B-cell non-Hodgkin lymphoma. Its work spans preclinical research and clinical-stage programs in RNA technology and lipid nanoparticle formulation.

5 investors

Accent Therapeutics is a biotechnology company focused on discovering and developing small molecule drugs to improve health outcomes for cancer patients. It operates in oncology-focused drug discovery and development.

5 investors

Accurx builds a communication platform that connects patients with healthcare professionals, supporting tasks like appointment booking, patient contact, referrals, video consultations, and health surveys. It serves NHS general practices and hospital trusts across the UK.

5 investors

Acesion Pharma is a biotech company developing pharmaceutical treatments. This page presents its leadership team and board of directors.

5 investors

Acurable manufactures wearable acoustic sensor devices for home-based patient monitoring and chronic disease management. The AcuPebble product family uses signal processing to extract disease-related biomarkers for diagnostic and disease management purposes.

5 investors

Adaptive Biotechnologies applies the genetics of the adaptive immune system to diagnostics and therapeutics, translating immune-system data into clinical insights for clinicians and biopharma companies. Its Immune Medicine Platform is used to detect, monitor, and treat disease.

5 investors

Adept Talent is the healthcare staffing arm of AdeptID, combining matching-model technology with a relationship-first staffing model to place clinicians and allied health professionals at healthcare facilities. It specializes in travel allied health placements for health systems facing workforce shortages.

5 investors

Adialante develops mobile MRI imaging units that arrive at clinical practices for diagnostic scanning, eliminating the need for hospital-based imaging facilities. The company serves private practices and clinics seeking to offer diagnostic-grade MRI services without capital investment or facility construction.

5 investors

Adient Medical develops absorbable medical devices, including implants designed to remain safe and effective during their useful lifetime and then dissolve on their own, avoiding removal procedures and related complications.

5 investors

AdrenoMed AG is a clinical-stage biopharmaceutical company developing Enibarcimab (formerly Adrecizumab), a first-in-class antibody targeting the peptide Adrenomedullin to restore vascular integrity in critically ill patients, with septic shock as its lead indication. It applies a biomarker-guided precision medicine approach to identify patients most likely to benefit and is based in the Berlin area of Germany.

5 investors

Aerie Pharmaceuticals develops ophthalmic pharmaceutical products including Rocklatan and Rhopressa for glaucoma and ocular hypertension, and AR-15512 for dry eye disease. The company serves eye care professionals and patients in the global ophthalmic pharmaceutical market.

5 investors

AeroSafe Global provides cold chain logistics and pharmaceutical distribution solutions through its proprietary "Cold Chain as a Service" model, serving specialty distributors, pharmaceutical manufacturers, health systems, specialty pharmacies, and direct-to-patient programs worldwide. The company operates across 80 countries with real-time tracking and advanced packaging technology to ensure the safe delivery of temperature-sensitive therapies.

5 investors

Agile Devices develops microcatheters using patented coaxial deflection technology for interventional vascular procedures. The company's Angler® device is designed to improve vessel navigation and reduce procedure time and cost in peripheral and coronary applications.

5 investors

Aidence, founded in 2015 in Amsterdam, was a radiology AI company that built clinical applications to help radiologists and physicians interpret medical images, focused on pulmonary nodule management and lung cancer screening. Its main product, Veye Lung Nodules (now DeepHealth Lung), was a CE-marked AI solution for lung nodule detection, classification, quantification, and growth assessment; the company was acquired by RadNet in 2022 and integrated into DeepHealth.

5 investors

Aillis is a Japanese healthcare technology company developing medical devices and technology aimed at making medical expertise more widely shared and accessible. It operates under a mission of creating open healthcare that can be co-created by many.

5 investors

Aja Labs develops skincare-infused synthetic hair fibers for protective styling, designed to nourish the scalp while reducing environmental waste. The company targets premium beauty brands seeking sustainable alternatives in the hair care market.

5 investors

AlayaCare Cloud is an AI-powered operating system for home-based care providers that integrates caregiving, scheduling, billing, and clinical workflows in a single platform. It serves home health agencies, private duty nursing, pediatric care, and specialty pharmacy organizations to optimize operations and reduce administrative burden.

5 investors